It could therefore be speculated that urine MCP-1 could be a marker of systemic inflammation secondary to systemic and local production, and could be an early marker of kidney inflammation and anticipate the development of AKI in patients with cirrhosis. The gene discussed is CCL2; the disease is acute kidney injury.